Oculis Holding AG OCS
NASDAQ OCS
$12.17 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Oculis Holding AG (OCS) Retained Earnings (2021 - 2026)

Oculis Holding AG (OCS) posted quarterly Retained Earnings of -$527.9 million for Q1 2026, down 48.88% year-over-year from -$1.0 billion in Q1 2025, and down 9.72% quarter-over-quarter from -$481.1 million in Q4 2025.

Analysis

Oculis Holding AG (OCS) Retained Earnings (2021 - 2026) Analysis & Trends

Oculis Holding AG's Retained Earnings history runs 6 years deep, the most recent figure standing at -$527.9 million for Q1 2026.

  • In Q1 2026, Retained Earnings fell 48.88% year-over-year to -$527.9 million; the TTM figure through Mar 2026 stood at -$527.9 million (down 48.88% YoY), while the FY2025 annual figure was -$463.8 million, down 42.88% from the prior year.
  • Retained Earnings for Q1 2026 stood at -$527.9 million, down from -$481.1 million in the prior quarter.
  • The five-year high for Retained Earnings was -$115.2 million in Q4 2022, with the low at -$527.9 million in Q1 2026.
  • The 5-year median for Retained Earnings is -$296.5 million (2024), against an average of -$315.6 million.
  • The sharpest annual moves came in 2023 and 2024: Retained Earnings sank 95.51% in 2023, then sank 38.55% in 2024.
  • Oculis Holding AG's Retained Earnings stood at -$115.2 million in 2022, then slumped by 95.51% to -$225.2 million in 2023, then plunged by 44.73% to -$326.0 million in 2024, then plunged by 47.59% to -$481.1 million in 2025, then declined by 9.72% to -$527.9 million in 2026.
  • Business Quant data shows OCS's Retained Earnings at -$527.9 million in Q1 2026, -$481.1 million in Q4 2025, and -$451.3 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.10 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -4.00 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 13.05 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -6.33 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 4.38 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.57 Bn
10 Oculis Holding AG 634.75 Mn 345.87 Mn - -535.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -535.62 Mn
Mar 31, 2026 -527.87 Mn
Dec 31, 2025 -481.09 Mn
Sep 30, 2025 -451.29 Mn
Jun 30, 2025 -415.69 Mn
Mar 31, 2025 -354.55 Mn
Dec 31, 2024 -325.97 Mn
Sep 30, 2024 -296.52 Mn
Jun 30, 2024 -261.75 Mn
Mar 31, 2024 -247.32 Mn
Dec 31, 2023 -225.22 Mn
Sep 30, 2023 -212.03 Mn
Jun 30, 2023 -188.93 Mn
Dec 31, 2022 -115.20 Mn
Dec 31, 2021 -78.39 Mn